Branle F - Search Results

1

ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Patients with ALK-Positive Non-Small Cell Lung Cancer Metastatic to the Brain and/or Leptomeninges.

Chow LQM, Barlesi F, Bertino EM, van den Bent MJ, Wakelee HA, Wen PY, Chiu CH, Orlov S, Chiari R, Majem M, McKeage M, Yu CJ, Garrido P, Hurtado FK, Arratia PC, Song Y, Branle F, Shi M, Kim DW. Chow LQM, et al. Among authors: branle f. Clin Cancer Res. 2022 Jun 13;28(12):2506-2516. doi: 10.1158/1078-0432.CCR-21-1838. Clin Cancer Res. 2022. PMID: 35091443

2

Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2.

Crinò L, Ahn MJ, De Marinis F, Groen HJ, Wakelee H, Hida T, Mok T, Spigel D, Felip E, Nishio M, Scagliotti G, Branle F, Emeremni C, Quadrigli M, Zhang J, Shaw AT. Crinò L, et al. Among authors: branle f. J Clin Oncol. 2016 Aug 20;34(24):2866-73. doi: 10.1200/JCO.2015.65.5936. Epub 2016 Jul 18. J Clin Oncol. 2016. PMID: 27432917 Clinical Trial.

3

First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study.

Soria JC, Tan DSW, Chiari R, Wu YL, Paz-Ares L, Wolf J, Geater SL, Orlov S, Cortinovis D, Yu CJ, Hochmair M, Cortot AB, Tsai CM, Moro-Sibilot D, Campelo RG, McCulloch T, Sen P, Dugan M, Pantano S, Branle F, Massacesi C, de Castro G Jr. Soria JC, et al. Among authors: branle f. Lancet. 2017 Mar 4;389(10072):917-929. doi: 10.1016/S0140-6736(17)30123-X. Epub 2017 Jan 24. Lancet. 2017. PMID: 28126333 Clinical Trial.

4

Ceritinib Efficacy and Safety in Treatment-Naive Asian Patients With Advanced ALK-Rearranged NSCLC: An ASCEND-4 Subgroup Analysis.

Tan DSW, Geater S, Yu CJ, Tsai CM, Hsia TC, Chen J, Lin MC, Lu Y, Sriuranpong V, Yang CT, Sen P, Branle F, Shi M, Wu YL. Tan DSW, et al. Among authors: branle f. JTO Clin Res Rep. 2020 Dec 17;2(3):100131. doi: 10.1016/j.jtocrr.2020.100131. eCollection 2021 Mar. JTO Clin Res Rep. 2020. PMID: 34589995 Free PMC article.

5

Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion study.

Fischer M, Moreno L, Ziegler DS, Marshall LV, Zwaan CM, Irwin MS, Casanova M, Sabado C, Wulff B, Stegert M, Wang L, Hurtado FK, Branle F, Geoerger B, Schulte JH. Fischer M, et al. Among authors: branle f. Lancet Oncol. 2021 Dec;22(12):1764-1776. doi: 10.1016/S1470-2045(21)00536-2. Epub 2021 Nov 12. Lancet Oncol. 2021. PMID: 34780709 Clinical Trial.

6

The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature.

Sculier JP, Ghisdal L, Berghmans T, Branle F, Lafitte JJ, Vallot F, Meert AP, Lemaitre F, Steels E, Burniat A, Mascaux C; European Lung Cancer Working Party. Sculier JP, et al. Among authors: branle f. Br J Cancer. 2001 May 4;84(9):1150-5. doi: 10.1054/bjoc.2001.1742. Br J Cancer. 2001. PMID: 11336463 Free PMC article.

7

Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy.

Branle F, Lefranc F, Camby I, Jeuken J, Geurts-Moespot A, Sprenger S, Sweep F, Kiss R, Salmon I. Branle F, et al. Cancer. 2002 Aug 1;95(3):641-55. doi: 10.1002/cncr.10710. Cancer. 2002. PMID: 12209758 Free article.

8

[The role of chemotherapy in the treatment of non-metastatic, non-small cell bronchial cancers].

Sculier JP, Berghmans T, Paesmans M, Branle F, Lemaitre F, Mascaux C, Meert AP, Steels E, Vallot F, Lafitte JJ. Sculier JP, et al. Among authors: branle f. Rev Med Brux. 2001 Dec;22(6):477-87. Rev Med Brux. 2001. PMID: 11811043 French.

9

A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis.

Mascaux C, Paesmans M, Berghmans T, Branle F, Lafitte JJ, Lemaitre F, Meert AP, Vermylen P, Sculier JP; European Lung Cancer Working Party (ELCWP). Mascaux C, et al. Among authors: branle f. Lung Cancer. 2000 Oct;30(1):23-36. doi: 10.1016/s0169-5002(00)00127-6. Lung Cancer. 2000. PMID: 11008007 Review.

10

Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis.

Steels E, Paesmans M, Berghmans T, Branle F, Lemaitre F, Mascaux C, Meert AP, Vallot F, Lafitte JJ, Sculier JP. Steels E, et al. Among authors: branle f. Eur Respir J. 2001 Oct;18(4):705-19. doi: 10.1183/09031936.01.00062201. Eur Respir J. 2001. PMID: 11716177 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page